Assertio Holdings, Inc. (ASRT)
13.74
+0.37
(+2.77%)
USD |
NASDAQ |
Mar 23, 15:38
Assertio Holdings EPS Diluted (Quarterly) : -1.858 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Castle Biosciences, Inc. | -0.0795 |
| ANI Pharmaceuticals, Inc. | 1.172 |
| Alkermes Plc | 0.291 |
| Catalyst Pharmaceuticals, Inc. | 0.4136 |
| Aura Biosciences, Inc. | -0.3963 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.93M |
| Revenue (Quarterly) | 13.54M |
| Total Expenses (Quarterly) | 25.47M |
| Enterprise Value | 62.64M |
| Gross Profit Margin (Quarterly) | 32.76% |
| Profit Margin (Quarterly) | -88.08% |
| Earnings Yield | -21.42% |
| Normalized Earnings Yield | -18.19 |